These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10227659)

  • 21. Proteolytic activity in amyotrophic lateral sclerosis IgG preparations.
    Nyormoi O
    Ann Neurol; 1996 Nov; 40(5):701-6. PubMed ID: 8957010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fab fragments from amyotrophic lateral sclerosis IgG affect calcium channels of skeletal muscle.
    Delbono O; Magnelli V; Sawada T; Smith RG; Appel SH; Stefani E
    Am J Physiol; 1993 Mar; 264(3 Pt 1):C537-43. PubMed ID: 8384783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antineural antibodies in the serum of patients with amyotrophic lateral sclerosis.
    Brown RH; Johnson D; Ogonowski M; Weiner HL
    Neurology; 1987 Jan; 37(1):152-5. PubMed ID: 3099227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer.
    Llinás R; Sugimori M; Cherksey BD; Smith RG; Delbono O; Stefani E; Appel S
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11743-7. PubMed ID: 8265620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature.
    Mehanna R; Patton EL; Phan CL; Harati Y
    J Clin Neuromuscul Dis; 2012 Dec; 14(2):82-5. PubMed ID: 23172389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of autoantibodies to potentially amyloidogenic protein, gamma-synuclein, in the serum of patients with amyotrophic lateral sclerosis and cerebral circulatory disorders.
    Roman AY; Kovrazhkina EA; Razinskaya OD; Kukharsky MS; Maltsev AV; Ovchinnikov RK; Lytkina OA; Smirnov AP; Moskovtsev AA; Borodina YV; Surguchov AP; Ustyugov AA; Ninkina NN; Skvortsova VI
    Dokl Biochem Biophys; 2017 Jan; 472(1):64-67. PubMed ID: 28421431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis.
    Appel SH; Smith RG; Alexianu M; Siklos L; Engelhardt J; Colom LV; Stefani E
    Clin Neurosci; 1995-1996; 3(6):368-74. PubMed ID: 9021258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased level of serum autoantibody against LG72 is a biosignature of amyotrophic lateral sclerosis.
    Hwang CS; Tsai CH; Liu GT; Li W; Chang HT
    Biomark Med; 2016; 10(1):73-9. PubMed ID: 26673967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of immune processes in amyotrophic lateral sclerosis pathogenesis.
    Alexianu ME
    Rom J Neurol Psychiatry; 1995; 33(3-4):215-27. PubMed ID: 8729177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS.
    Chang Q; Martin LJ
    Neurobiol Dis; 2016 Sep; 93():78-95. PubMed ID: 27151771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports.
    Takahashi H; Noto YI; Makita N; Kushimura-Okada Y; Ishii R; Tanaka A; Ohara T; Nakane S; Higuchi O; Nakagawa M; Mizuno T
    BMC Neurol; 2016 Nov; 16(1):229. PubMed ID: 27863479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis.
    Appel SH; Smith RG; Alexianu MF; Engelhardt JI; Stefani E
    Adv Neurol; 1995; 68():47-57. PubMed ID: 8787242
    [No Abstract]   [Full Text] [Related]  

  • 33. Amyotrophic lateral sclerosis: an unconventional autoimmune disease?
    Drachman DB; Kuncl RW
    Ann Neurol; 1989 Aug; 26(2):269-74. PubMed ID: 2673004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyotrophic lateral sclerosis associated with IgG anti-GalNAc-GD1a antibodies.
    Yamazaki T; Suzuki M; Irie T; Watanabe T; Mikami H; Ono S
    Clin Neurol Neurosurg; 2008 Jul; 110(7):722-4. PubMed ID: 18450370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroconversion of anti-GM1 antibodies in patients with amyotrophic lateral sclerosis.
    Haggiag S; Steiner-Birmanns B; Wirguin I; Sicsic C; Brenner T; Steiner I
    Neurology; 2004 Aug; 63(4):755-6. PubMed ID: 15326266
    [No Abstract]   [Full Text] [Related]  

  • 36. Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease.
    Smith RG; Kimura F; Harati Y; McKinley K; Stefani E; Appel SH
    Muscle Nerve; 1995 Jun; 18(6):620-7. PubMed ID: 7753125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS).
    Niebroj-Dobosz I; Dziewulska D; Janik P
    Folia Neuropathol; 2006; 44(3):191-6. PubMed ID: 17039414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor neuron disease: Can gluten sensitivity mimic amyotrophic lateral sclerosis?
    Wood H
    Nat Rev Neurol; 2015 Jun; 11(6):308. PubMed ID: 25917703
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analysis of serum antibodies to nerve tissue antigens in patients with lateral amyotrophic sclerosis].
    Shanina NA; Sveĭkata AP; Zavalishin IA; Gel'fand VI
    Biull Eksp Biol Med; 1993 Feb; 115(2):169-73. PubMed ID: 7519064
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Fu X; Zhu W; Guo Z; Shu G; Cui F; Yang F; Zhang Y; Ren Y; Zhang X; Zhang X; Chen Z; Ling L; Huang X; Zhang J
    J Neurol Sci; 2017 Jun; 377():79-84. PubMed ID: 28477714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.